IBD Disease Course of Infliximab-na ïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®
Condition: Inflammatory Bowel Diseases Intervention: Other: Biocollection Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2023 Category: Research Source Type: clinical trials
Efficacy and safety of s.c. infliximab in patients switched from i.v. formulation of infliximab
Conditions: Inflammatory Bowel Diseases; Rheumatologic Disease Intervention: Drug: CT-P13 Sponsor: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2023 Category: Research Source Type: clinical trials